Retraction of High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial. J Nutr 2018;148(8):1380-6
- PMID: 33974700
- DOI: 10.1093/jn/nxab074
Retraction of High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial. J Nutr 2018;148(8):1380-6
Retraction of
-
High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.J Nutr. 2018 Aug 1;148(8):1380-1386. doi: 10.1093/jn/nxy116. J Nutr. 2018. Retraction in: J Nutr. 2021 May 11;151(5):1362. doi: 10.1093/jn/nxab074. PMID: 29982544 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources